about
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensGenetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus.The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38/JNK signalling.Isolation and Characterization of Antigen-Specific Plasmablasts Using a Novel Flow Cytometry-Based Ig Capture Assay.Optimisation of ex vivo memory B cell expansion/differentiation for interrogation of rare peripheral memory B cell subset responses.The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus
P50
Q33720317-8AB2D788-9B56-4C94-84C3-9B2CAE49C3A0Q36343939-5E911ACD-D9F7-4908-BF8D-A41FCC933371Q38818994-BAFFA83F-47E5-4EBF-8126-7B88605841F2Q40076470-AE28AB44-CA04-41AD-8124-A3C2187EE13EQ47423643-7E6082EF-09EA-48C8-AA94-3A2D4778A89AQ52626499-141AC3B3-630A-48B5-9C46-AEEF429944BBQ90575861-9A5D3ED4-9FAA-48DB-BA39-2AABE6B79DF7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher L Pinder
@ast
Christopher L Pinder
@en
Christopher L Pinder
@es
Christopher L Pinder
@nl
type
label
Christopher L Pinder
@ast
Christopher L Pinder
@en
Christopher L Pinder
@es
Christopher L Pinder
@nl
prefLabel
Christopher L Pinder
@ast
Christopher L Pinder
@en
Christopher L Pinder
@es
Christopher L Pinder
@nl
P106
P21
P31
P496
0000-0003-4149-226X